Note 8 - Accrued Expenses

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

	March 31,		December 31,
	2024		2023
Compensation and related expenses	$	8,595	$	11,828
Professional fees		3,434		3,240
Operating lease liability – current		2,129		2,133
Discontinuation of software development project		1,904		1,904
Income taxes payable		1,490		1,240
Clinical trial costs		249		460
Share based compensation		160		-
Other		477		394
Total	$	18,438	$	21,199